Small Molecule Next-Gen Phenotypic White Paper | Sartorius

White Paper: Phenotypic Screening

This white paper, analyzes the pros and cons of target and phenotypic screening and explains why top pharmaceutical companies are implementing a more holistic and balanced approach for accelerating drug discovery.

It highlights the advantages of using the Intellicyt platform over traditional flow cytometry and imaging systems.


Complete the form to download

Please provide your information to download this resource

icon-shopping-cart
Ready to Buy?